Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise Mailing List ATTEND Show Overview Who Attends Stay Updated FAQ COMMUNITIES Drug Development Clinical/TMF BD&L PR & Communications PROGRAM 2026 Speakers 2026 Full Agenda Drug Development Sessions Clinical/TMF Sessions BD&L Sessions PR & Communications Sessions Speaker Resources VENUE Encore Boston Harbor Hotel & Casino OUTSOURCING AWARDS Awards Overview 2026 Judges Join Our Mailing List 2026 CALL FOR SPEAKERS PARTNERS 2026 Partners 2026 Partner Opportunities Partner Resources Become a Partner REGISTER ATTEND Show Overview Who Attends Stay Updated FAQ COMMUNITIES Drug Development Clinical/TMF BD&L PR & Communications PROGRAM 2026 Speakers 2026 Full Agenda Drug Development Sessions Clinical/TMF Sessions BD&L Sessions PR & Communications Sessions Speaker Resources VENUE Encore Boston Harbor Hotel & Casino OUTSOURCING AWARDS Awards Overview 2026 Judges Join Our Mailing List 2026 CALL FOR SPEAKERS PARTNERS 2026 Partners 2026 Partner Opportunities Partner Resources Become a Partner REGISTER Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise Mailing List Powerhouse Communities: Drug Development Home Clinical/ TMF Home BD&L Home PR & Comms Home Please check back regularly as we are adding new speakers on a daily basis. Meet the 2026 Speakers: Ingrid Abrahamsen Executive Director, Head of Clinical Operations Fulcrum Therapeutics Brian Alexander, MD, MPH CEO Valo Health Kevin Anderson Sr. Director, Clinical Operations, Therapeutics Moderna Christopher Arendt Chief Science Officer, Head of Research Takeda Carla Bauer Director, Oncology Search and Evaluation, Business Development & Licensing Merck Daniel Beal Director, Clinical Program Lead Mediar Therapeutics Paul Bolno President & CEO Wave Life Sciences Ben Bradford Head of External Affairs MassBio Carolyn Britten, MD VP, Clinical Development, Solid Tumors, BeOne Jared Brooslin Senior Manager, Trial Master File Intellia Therapeutics Karim Budhwani CEO-Scientist CerFlux Stephen Bychowski General Counsel, Assistant General Counsel BD&L Pharma Sanofi Ventures Moitreyee Chatterjee-Kishore Head of Oncology Development Astellas Pharma Inc. Priya Chaturvedi VP, Head of Global Clinical Quality Eisai Kleem Chaudhary Chief Executive Officer Hyku Biosciences Ron Cooper CEO enGene Helena Cowley Director, Global Alliance Management Takeda Ann DeWitt Manisha Desai Senior Vice President, Product Development, Product Development & Supply Bristol Myers Squibb Scott Dewire Corporate Senior Vice President & Head of Global Business Development Boehringer Ingelheim Debbie Etchison Executive Director, Head of Corporate Affairs Alkeus Pharmaceuticals Stephanie Fagan Chief Corporate Affairs Officer Definium Therapeutics Adam Feire Head of Business Development and External Innovation Biogen Susan Fitzpatrick-Napier CEO TrialWire Tori Fort SVP, Corporate Strategy and Corporate Affairs Ovid Therapeutics Kristen Fortney, PhD Co-Founder & CEO BioAge Labs Diana Gallagher, MD SVP, Head of Clinical Development for MS, Immunology and Alzheimer Biogen Sarah Ganley Associate Director of Standards & Processes Arrowhead Pharmaceuticals Nicole Glazer Senior Vice President, R&D Data, Digital, and Technology Takeda Kelly Gold CFO CAMP4 Therapeutics Rob Goldstein-Mahon Executive Director, Patient Advocacy Ionis Pharmaceuticals Colleen Graham SVP, Clinical Operations Mediar Therapeutics Abigail Gregor Partner, Life Sciences Licensing & Collaborations Ropes & Gray Joseph Grieco VP of Clinical Development Tris Pharma Sue Hager Advisory Partner Andreessen Horowitz Rebecca Halbur Associate Director, TMF Records Mangement, Cinical Trial Systems & Operations Moderna Catherine Hall Head of GXP Quality Assurance Egnyte Alison Handley VP and Head, Center for External Innovation Takeda Jamie Harrop Vice President Clinical Operations Beam Therapeutics Sheela Hegde Managing Partner & Global Head Health Advances Meredith Hightower Director, Strategic Site Partnerships, Clinical Field Excellence, CSM AbbVie Echo Hindle-Yang Founder and Chief Executive Officer MSQ Ventures Mary Jane Hinrichs Senior Vice President, Early Development, Ipsen Narimon Honarpour, MD, PhD Senior Vice President, Global Development Amgen Christelle Huguet Executive Vice President, Head of R&D Ipsen Youssef Idelcaid Head of AI Research Center Gilead Sciences Darren Incorvaia Staff Writer Fierce Biotech Anthony Jarkowski Senior Vice President, Primary Focus Lead, Head of Immuno-Oncology Astellas Pharma Jose Juves Chief Corporate & Patient Affairs Officer Dyne Therapeutics Ariel Katz CEO and Co-founder H1 Abbas Kazimi Chief Executive Officer Nimbus Therapeutics Adam Keeney Executive Vice President and Head of Corporate Development Biogen Jared Kelly CEO Oncolytics Biotech Matthew Kennedy AVP, Neuroscience and Neuroimmunology Lead Merck Peter Kilford, PhD Associate Vice President, Software Business Development Simulations Plus Jessica Kirshner Vice President of Oncology and Immuno-Oncology Regeneron Sheri Kuss Sr. Director, GCP Quality Vaccines Category Head Pfizer Rita Lemming Director, Clinical Operations Fulcrum Therapeutics Lizabeth Leveille Vice President, BD&L and Head, Boston Innovation Hub & Discovery Transactions Merck Michael Levey Director, Global Media Relations Merck Stacy Lindborg, PhD President, Chief Executive Officer & Board Director IMUNON, Inc. Alex Loboda Director, Clinical Quality Korro Bio Karla MacDonald Chief Corporate Affairs Officer Entrada Therapeutics Maria Maccecchini CEO Annovis Kellie Malloy Foerter VP, Global Trial Management Bristol Myers Squibb John Maraganore, PhD Founding and Co-CEO, Corsera Health, Alnylam Pharmaceuticals; CEO and Principal, JMM Innovations Gabrielle Masson Senior Editor Fierce Biotech Jennifer McCafferty, PhD, Senior Vice President, Head of CMC-Regulatory and MRL Quality Assurance, Merck Theresa McNeely Chief Communications Officer Lifordi Immunotherapeutics, Inc. Liza Micioni Sr. Director, Head of Clinical Operations Tris Pharma, Inc. Amber Monaghan Director IPM Ahmed Mousa Chief Executive Officer Vicore Pharma John Murray VP Global Business Development & Country Head UK SanaClis Nikhil Mutyal Head of Search and Evaluation - Respiratory & Immunology AstraZeneca Miki Nakamori Executive Director, Head of Scouting & Transaction, PFGR/BR, Business Development Astellas Pharma Inc. Tatiana Novobrantseva, PhD Chief Scientific Officer NextPoint Therapeutics Kate O'Malley Vice President, Corporate Affairs Moderna Emily Oldshue Partner Ropes & Gray Jacob Petersen Senior Vice President, Diabetes, Obesity and MASH Therapeutic Area Novo Nordisk Maha Radhakrishnan Executive Partner, Private Equity Sofinnova Investments Bhaskar Rege, PhD Senior Vice President, Pharmaceutical and Early-Stage Development Alkermes Kristen Riemenschneider Partner Freshfields Kendra Rose Senior Vice President, Head of BD&L/OI New Platforms Cardiovascular & Immunology Bayer Dennis Salotti Sr. Director & Head, Strategic Outsourcing & Clinical Innovation Jazz Pharmaceuticals Amber Salzman, Ph.D. CEO Epicrispr Biotechnologies Marc Schwabish Chief Business Officer Tectonic Therapeutic Evan Seigerman Evan Seigerman, Managing Director, Head of Healthcare Research BioPharma & Biotechnology BMO Capital Markets Madeleine Shin Executive Director, Global Head of External Communications and Media Biogen David Soergel, MD Chief Medical Officer Madrigal Erik Sokolowski Zevra Therapeutics Tracy Sorrentino Vice President, Corporate Affairs Sarepta Therapeutics Rob Staszewski Associate Director, Clinical Oversight & Systems United Therapeutics Mary Kathryn Steel Executive Director of Leadership and Enterprise Communications Bristol Myers Squibb Charles Theuer M.D. Ph.D. Chief Medical Officer Halozyme Claris Tsang Munksgaard Global Business Development and Licensing EMD Serono, Inc Peter Tummino President of Research & Development Nimbus Therapeutics James Waldron UK/EU Bureau Chief Fierce Biotech Juliet Williams, PhD Head of Research Kymera Vanessa Wolfeler CEO SERB Pharma